Galectin Therapeutics: Board
CommitteesIndependence
Kevin D. FreemanDirectorAudit, Compensation, Nominating and Corporate GovernanceIndependent14 yrNot disclosed
Elissa J. Schwartz, Ph.D.DirectorDirectors, Nominees and Named Executive Officers, Nominating and Corporate GovernanceIndependent8 yrNot disclosed
Kary EldredDirectorAuditIndependent7 yrNot disclosed
3 seats

The board of the latest proxy statement.